AEG vs CRBG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a Piotroski F-Score of 5/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a seemingly attractive valuation with a P/E of 8.47 well below sector average and a current price below the Graham Number of $11.87, earnings volatility is extreme—recent YoY EPS growth is -3075% and Q/Q EPS growth is -1170%, signaling severe deterioration. Dividend strength is solid at 70/100 with a 5.76% yield and sustainable 44.48% payout ratio, but insider sentiment is weak at 40/100 and technical trend is deeply bearish at 10/100. Combined with erratic earnings surprises averaging -745.99% over the last four quarters, the stock appears fundamentally deteriorating despite surface-level value appeal.
Corebridge Financial exhibits significant fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health. Despite a low forward P/E of 4.47 and bullish analyst targets, the company is suffering from a severe earnings collapse (-58.10% YoY) and consistent quarterly misses. Massive insider selling totaling over $1.76 billion suggests a lack of confidence from major stakeholders. The combination of negative ROE and a dangerously low quick ratio (0.24) points toward a potential value trap.
Compare Another Pair
Related Comparisons
AEG vs CRBG: Head-to-Head Comparison
This page compares Aegon Ltd. (AEG) and Corebridge Financial, Inc. (CRBG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.